Category: Dangerous Drugs


DANGEROUS DRUG – Reglan

Reglan is a prescription drug pushed by pharmaceutical companies to patients to treat Gastroesophageal reflux (GER) Gastroesophageal reflux disease (GERD). Many studies dating back from the 1970s have shown that Reglan is ineffective in resolving GER and GERD. A 2006 study published in Nature Clinical Practice: Gastroenterology & Hepatology concluded that “the evidence base for… read more


NEW MEXICO DANGEROUS DRUGS – AVANDIA RESEARCHERS TIED TO CONFLICTS OF INTERESTS

According to Bloomberg News, 94% of researchers who found positive results from using Avandia had financial ties to pharmaceutical companies. Avandia is a controversial diabetes drug that has been linked to increased sharp increased risk of heart attack and death. Despite the FDA’s issuance of a formal safety alert concerning the risks associated with Avandia,… read more



New Mexico Dangerous Drugs – GlaxoSmithKline Has Duty To Warn Of Avandia Risks

The U.S. Senate Finance Committee has recently issued a report on Avandia, a controversial drug produced by GlaxoSmithKline (“GSK”) to control diabetes. According to the report, GSK knew of possible heart attack risks tied to Avandia many years before the information became public. The report unequivocally states “GSK had a duty to sufficiently warn patients… read more



Harvard Study Links Avandia To Increased Risk of Heart Attack

A soon-to-be-published report by the American Diabetes Association has found that the number of heart attacks by diabetic patients who took Avandia is double that of those who took a different oral diabetic medication. In the study, Harvard University researchers analyzed clinical data from more than 26,375 patients from 2000 to 2006 in the Boston… read more


New Mexico Dangerous Drugs – Wyeth v. Levine Should Apply To Generic Drugs

In a victory for consumers, last Friday the Fifth Circuit Court of Appeals agreed with the lower court that individuals may sue generic drug makers in state court for the “failure to warn” consumers of potentially dangerous side effects from taking their drugs. This decision shadows last March’s Supreme Court decision in Wyeth v. Levine,… read more